Latest Oncologists Stories
SAN DIEGO, May 15, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that clinical data from a Phase 1b trial of PEGPH20 (PEGylated Recombinant Human Hyaluronidase), an investigational new biologic, in combination with gemcitabine for treatment of patients with stage IV metastatic pancreatic cancer will be presented at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting. (Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO) In...
CLEVELAND, May 15, 2013 /PRNewswire/ -- Researchers from University Hospitals Case Medical Center's (UHCMC) Seidman Cancer Center will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials. Results from a large-scale, randomized trial demonstrated that the use of tailored, web-based videos delivering educational information to patients before an oncologist visit can significantly improve knowledge and...
Smith & Jones Wins Bronze Telly Award for Hospital System Cancer Brand Spot. Troy, NY (PRWEB) May 14, 2013 Healthcare marketing specialists, Smith & Jones, announced today its receipt of a 2013 Bronze Telly Award for the Ellis Medicine Oncology Brand TV Spot. This is the second Telly Award that the agency has received for this campaign. The Telly Awards honor the finest film and video productions, web commercials, videos and films, and local, regional and cable commercials and...
Data from Pipeline Molecules Targeting Key Cancer Pathways to be Presented INDIANAPOLIS, May 14, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present data from key molecules that make up its clinical oncology pipeline during the 49(th) Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Chicago, Ill. from May 31 - June 4, 2013. Lilly Oncology's pipeline is one of the most robust in the industry, with more than 20 molecules in early- and...
The Bladder Cancer Advocacy Network (BCAN) has granted $300,000 to three exceptional up and coming researchers through its Young Investigator Awards program. Bethesda, MD (PRWEB) May 11, 2013 Just as National Cancer Research month begins, the Bladder Cancer Advocacy Network (BCAN) has announced the recipients of its Young Investigator Awards. BCAN’s Scientific Review Group, chaired by Matt Milowsky, MD at the University of North Carolina’s Lineberger Comprehensive Cancer Center,...
A Therapy as Efficacious as FOLFIRINOX, but Better Tolerated, Will Quickly Become the New Standard of Care in Pancreatic Cancer, According to a New Report from Decision Resources BURLINGTON, Mass., May 7, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the pancreatic cancer therapy market will nearly double to $1.3 billion in 2022, owing to the launch and rapid uptake of three...
SAN DIEGO, May 3, 2013 /PRNewswire-USNewswire/ -- Today, the American Urological Association (AUA) released a new Guideline on the Early Detection of Prostate Cancer, which addresses prostate cancer early detection for the purpose of reducing prostate cancer mortality. The guideline was developed through a rigorous, systematic review of published literature (including data extraction and analysis), and updates the AUA's Best Practice Statement on Prostate-Specific Antigen (PSA),...
New app gives urologists the ability to share three-dimensional models of vital organs with patients for more complete, in-depth consultations SAN DIEGO and VANCOUVER, British Columbia, May 3, 2013 /PRNewswire/ -- GenomeDx Biosciences today announced the launch of UroSketch 3D(TM), an application available in Apple's App Store and designed specifically for the iPad. The app, which provides a three-dimensional model of the prostate, bladder and surrounding organs for use by physicians...
Pancreatic Cancer Becomes the Fourth Tumor Type Evaluated as Part of the OGX-427 ORCA(TM) Program, In Addition to Bladder, Lung and Prostate Cancers BOTHELL, Wash. and VANCOUVER, British Columbia, May 1, 2013 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced plans for the initiation of the Rainier(TM) trial, an investigator-sponsored, randomized, placebo-controlled Phase 2 trial evaluating OGX-427 in combination with ABRAXANE(®) (paclitaxel protein-bound...
Industry Veteran to Lead Metamark Genetics in Commercialization of Novel Prognostic Tests for Prostate and Other Cancers CAMBRIDGE, Mass., April 30, 2013 /PRNewswire/ -- Metamark Genetics, Inc., a leader in the discovery of novel molecular prognostic and diagnostic tests for cancer, today announced that industry veteran Shawn M. Marcell has been named the company's new president and chief executive officer. Mr. Marcell succeeds interim executive Michael Kauffman, M.D., who will...
